PT-141 (Bremelanotide)
FDA ApprovedMelanocortin Receptor Agonist | Sexual Dysfunction Treatment
Community Research
Join others researching PT-141 — share findings, ask questions, and learn from real experiences
FDA-approved melanocortin receptor agonist for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Works centrally in the nervous system to trigger sexual arousal pathways independent of vascular mechanisms, unlike traditional ED medications.
Selectively activates melanocortin receptors (MC3R/MC4R) in the central nervous system, triggering sexual arousal pathways independent of peripheral vascular mechanisms. Works within 45 minutes with effects lasting 6-12 hours.
Molecular Data
Research Indications
FDA-approved for treatment of HSDD in premenopausal women.
Effective in men including PDE5 inhibitor-resistant cases via CNS pathways.
Enhances sexual arousal and desire in women.
Reduces distress related to low sexual desire.
Enhanced satisfaction reported in clinical trials.
Dosing Protocols
Subcutaneous injection is the FDA-approved route. Administered 45-60 minutes before anticipated sexual activity.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Female HSDD (FDA-approved) | 1.75mg | As needed, max 1 dose/24hr | SubQ |
| Male Erectile Dysfunction | 1-2mg | As needed, 45-60min before activity | SubQ |
| Female Arousal Disorder | 0.75-1.25mg | As needed, max 1 dose/24hr | SubQ |
| Low Starting Dose | 0.5mg | Test dose for tolerance assessment | SubQ |
Reconstitution Instructions
- PT-141 lyophilized powder vial
- Bacteriostatic water (1-2mL)
- Insulin syringe (29-31 gauge)
- Alcohol swabs
- Sterile mixing syringe
- 1 Allow vial to reach room temperature (15-20 minutes)
- 2 Clean vial tops with alcohol swabs
- 3 Draw 1-2mL bacteriostatic water
- 4 Inject BAC water slowly down vial side
- 5 Gently swirl until fully dissolved (do not shake)
- 6 Solution should appear clear and colorless
- 7 Store reconstituted solution refrigerated
- 8 Use within 30 days of reconstitution
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Nausea (40%)
- Flushing (20%)
- Headache (11%)
- Injection site reactions
Stop Signs - Discontinue if:
- Severe or persistent nausea/vomiting
- Significant blood pressure drop or dizziness
- Chest pain or irregular heartbeat
- Severe headache or vision changes
- Prolonged erection exceeding 4 hours
Contraindications
- Uncontrolled hypertension
- Cardiovascular disease
- Use of nitrate medications
- Pregnancy or breastfeeding
Quality Checklist
Good Signs
- FDA-approved pharmaceutical grade (Vyleesi) from licensed pharmacy
- White crystalline powder (pure PT-141)
- Clear solution when reconstituted
- Proper labeling with concentration and purity
Warning Signs
- Compounded versions - ensure pharmacy is licensed and follows USP standards
Bad Signs
- Colored or oily appearance indicating impurities or degradation
- Cloudy solution after reconstitution
- Unknown source without quality documentation
Frequently Asked Questions
How is PT-141 different from Viagra if both treat erectile dysfunction?
Completely different mechanisms. Viagra (sildenafil) works peripherally by dilating blood vessels in the penis (PDE5 inhibition). PT-141 works centrally in the brain via melanocortin receptors to trigger sexual desire and arousal independent of blood flow. PT-141 can even work in PDE5 inhibitor-resistant cases because it bypasses the vascular system entirely.
Why does PT-141 cause nausea in 40% of people?
PT-141 activates melanocortin receptors broadly in the brain, not just sexual arousal centers. Off-target activation in nausea-control areas is a known side effect. Taking an anti-nausea medication 30 minutes before PT-141 (as recommended in the file) significantly reduces this. Many users find pre-medication worthwhile for the benefit.
Can women use PT-141, or is it only for men?
Women can use it. PT-141 is FDA-approved for female HSDD (hypoactive sexual desire disorder) at 1.75mg. Men use 1-2mg for ED. The mechanism is identical—melanocortin receptor activation increases sexual arousal in both sexes. It's one of the few sexual enhancement drugs with proven efficacy specifically in women.
Is PT-141 safe if I have high blood pressure?
No. PT-141 raises blood pressure and causes flushing. The file lists uncontrolled hypertension as a contraindication. Monitor your BP closely if you have hypertension, and avoid combining with blood pressure-lowering medications. Nitrates are specifically contraindicated due to severe hypotension risk.
References
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials (RECONNECT)Kingsberg SA, Clayton AH, Portman D, et al.Obstetrics & Gynecology (2019)
Two identical phase 3, randomized, double-blind, placebo-controlled trials (NCT02333071 and NCT02338960). Bremelanotide 1.75mg SubQ significantly improved sexual desire and reduced related distress in premenopausal women with HSDD.
- Double-Blind, Placebo-Controlled Evaluation of Intranasal PT-141 in Healthy Males and Patients with Erectile DysfunctionDiamond LE, Earle DC, Rosen RC, et al.Urology (2004)
Intranasal PT-141 produced dose-dependent increase in erectile activity at doses >7mg, with onset in ~30 minutes. Safe and well-tolerated in both healthy men and ED patients.
- The Neurobiology of Bremelanotide for the Treatment of HSDD in Premenopausal WomenClayton AH, Kingsberg SA, Goldstein I, et al.CNS Spectrums (2021)
Bremelanotide activates MC4R in the medial preoptic area of the hypothalamus, increasing dopamine release. CNS mechanism of action independent of peripheral vascular effects.
- Salvage of Sildenafil Failures with Bremelanotide: A Randomized, Double-Blind, Placebo-Controlled StudySafarinejad MRJournal of Urology (2008)
342 men with ED unresponsive to sildenafil randomized to 10mg bremelanotide intranasal spray vs placebo. Demonstrated effectiveness in PDE5 inhibitor-resistant cases.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.